Dewmar International BMC, Inc. (OTCMKTS:DEWM) Shooting for the Stars
A new wave of investor attention has hit Dewmar International BMC, Inc. (OTCMKTS:DEWM) following the attempt of CEO, Dr. Marco Moran, to give the public another reason to invest in DEMW. What better way to jack up your shares than with a new press announcement on marijuana? DEWM has a co-branding and professional consulting services agreement with The Industrial Hemp and Medical Marijuana Consulting Company, Inc., a wholly-owned subsidiary of Hemp, Inc. (OTCMKTS:HEMP).
DEWM‘s shares have rocketed through the roof as their price has increased 20 fold over the past 6 days, showing that investor’s enthusiasm doesn’t seem to be slowing down just yet. In a paid pod-cast on thestockradio.com, Dr. Moran hints yet again toward the move to the marijuana and hemp sector, and talks about the DEWM‘s relaxation drink “Lean” . In our previous article we familiarized ourselves with the product.
In the interview CEO, Dr. Moran covers LEAN’s history, sales records, and the strategic marketing changes that have been implemented, as well as the results that the company expects them to bring. Dr. Moran also mentioned how sales records were “unique” and tried to explain, the revenue decrease from $1.5 million, down to just about a quarter of a million in 2013.
Without doubt DEWM want to convince the public that they have a thing going on. With a couple of press announcements that may have been like music for traders’ ears, and an explained strategy for the growth ahead, investors are hoping for more days in the green.
Just before the price hike to $0.085, shares were trading at $0.005 on the 4th of January. In the next six sessions the share volume reached almost 4 billion, which converts into 12 million in dollar volume. That was a 2000% jump in share value – very impressive for a one man company.
It is questionable who is looking after the interest of Shareholders in the long run. Dr. Moran’s has done a few controversial deeds in the past. Just in 2012 investors lost over 90% in share value while he received a hefty $3.15 million in stock awards. There was also a claim filed against Dr. Moran and DEWM‘s wholly-owned subsidiary DSD Network of America, Inc. Allegedly Dr. Moran engaged in various acts of misconduct and breaches of his fiduciary duties to the corporation.
Currently, there are plenty of companies with failed pumps in their past, which are trying to attract investor attention with a sudden move to the marijuana and hemp sector.
Let’s not forget that DEWM have limited options if things don’t work out as planned. Their third quarter balance shows us why.
- Cash $12 thousands
- Current Liabilities $1.1 million
- revenue $50 thousand
- Net loss $340 thousand
On the 6th of February pennystockprophecy was promoting the stock, This could have helped the momentum that had developed from prior announcements. In FINRA’s latest investor alert, they comment on Marijuana Stock Scams. Learning how to spot a potential investment scam can save you lots of money. Doing your due diligence when investing in a company is crucial, especially when looking at a micro cap which suddenly switches to a hot sector.
